Search research articles
Contact Us
Filters
Showing results (371-380 of 404) with videos related to
Page
of 41
Sort By:
Cell Host & Microbe
|
January 16, 2015
A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys
Alexander D Douglas, G Christian Baldeviano, Carmen M Lucas, et al.
Plos One
|
February 25, 2012
Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors
Susanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Nature Communications
|
September 3, 2017
Hepcidin is regulated by promoter-associated histone acetylation and HDAC3
Sant-Rayn Pasricha, Pei Jin Lim, Tiago L Duarte, et al.
Frontiers in Immunology
|
August 2, 2021
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial
Hans de Graaf, Ruth O Payne, Iona Taylor, et al.
Cell Reports
|
April 4, 2019
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans
Pramila Rijal, Sean C Elias, Samara Rosendo Machado, et al.
JCI Insight
|
June 15, 2017
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies
Ruth O Payne, Sarah E Silk, Sean C Elias, et al.
Nature Communications
|
November 29, 2013
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
Katie J Ewer, Geraldine A O'Hara, Christopher J A Duncan, et al.
Frontiers in Immunology
|
September 8, 2022
Repeat controlled human malaria infection of healthy UK adults with blood-stage <i>Plasmodium falciparum</i>: Safety and parasite growth dynamics
Jo Salkeld, Yrene Themistocleous, Jordan R Barrett, et al.
The Journal of Clinical Investigation
|
February 9, 2022
Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2
Elena Mitsi, Jesús Reiné, Britta C Urban, et al.
Plos One
|
July 30, 2011
Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909
Christopher J A Duncan, Susanne H Sheehy, Katie J Ewer, et al.
Page
of 41
Search research articles
Search
Showing results (371-380 of 404) with videos related to
Sort By:
Page
of 41
Cell Host & Microbe
|
January 16, 2015
A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys
Alexander D Douglas, G Christian Baldeviano, Carmen M Lucas, et al.
Plos One
|
February 25, 2012
Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors
Susanne H Sheehy, Christopher J A Duncan, Sean C Elias, et al.
Nature Communications
|
September 3, 2017
Hepcidin is regulated by promoter-associated histone acetylation and HDAC3
Sant-Rayn Pasricha, Pei Jin Lim, Tiago L Duarte, et al.
Frontiers in Immunology
|
August 2, 2021
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial
Hans de Graaf, Ruth O Payne, Iona Taylor, et al.
Cell Reports
|
April 4, 2019
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans
Pramila Rijal, Sean C Elias, Samara Rosendo Machado, et al.
JCI Insight
|
June 15, 2017
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies
Ruth O Payne, Sarah E Silk, Sean C Elias, et al.
Nature Communications
|
November 29, 2013
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
Katie J Ewer, Geraldine A O'Hara, Christopher J A Duncan, et al.
Frontiers in Immunology
|
September 8, 2022
Repeat controlled human malaria infection of healthy UK adults with blood-stage <i>Plasmodium falciparum</i>: Safety and parasite growth dynamics
Jo Salkeld, Yrene Themistocleous, Jordan R Barrett, et al.
The Journal of Clinical Investigation
|
February 9, 2022
Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2
Elena Mitsi, Jesús Reiné, Britta C Urban, et al.
Plos One
|
July 30, 2011
Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909
Christopher J A Duncan, Susanne H Sheehy, Katie J Ewer, et al.
Page
of 41